Scott Haden Kollins
Professor in Psychiatry and Behavioral Sciences
Education & Training
Ph.D., Auburn University 1997
Scott H. Kollins, PhD received his undergraduate degree in psychology from Duke and his Master’s and Doctorate degrees in Clinical Psychology from Auburn University. After completing his clinical internship at the University of Mississippi Medical Center, where he served as Chief Intern, he joined the faculty of the Department of Psychology at Western Michigan University for three years, before joining the Duke faculty in 2000. Dr. Kollins has published more than 125 scientific papers in peer-reviewed journals. Over the past 10 years, his research has been supported by 6 different federal agencies, including NICHD, NIDA, NIMH, NIEHS, NINDS, and EPA, and he currently holds a mid-career K24 award from NIDA. He has also served as PI on more than 40 industry-funded clinical trials and is a consultant to a number of pharmaceutical companies in the area of ADHD clinical psychopharmacology. He has served as a standing member of the Child Psychopathology and Developmental Disabilities study section and also served as an ad-hoc reviewer for 10 additional NIH study sections and 7 international granting agencies. He is an Associate Editor for the Journal of Attention Disorders and has reviewed for more than 50 different peer-reviewed journals. He is an elected member of the College on Problems of Drug Dependence and the American College of Neuropsychopharmacology. Dr. Kollins is a licensed clinical psychologist and maintains a practice through the ADHD Program’s outpatient clinic. His research interests are in the areas of psychopharmacology and the intersection of ADHD and substance abuse, particularly cigarette smoking.
Sanchez, CE, Barry, C, Sabhlok, A, Russell, K, Majors, A, Kollins, SH, and Fuemmeler, BF. "Maternal pre-pregnancy obesity and child neurodevelopmental outcomes: a meta-analysis." Obesity reviews : an official journal of the International Association for the Study of Obesity 19.4 (April 2018): 464-484. (Review) Full Text
Sweitzer, MM, Kollins, SH, Kozink, RV, Hallyburton, M, English, J, Addicott, MA, Oliver, JA, and McClernon, FJ. "ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 43.4 (March 2018): 851-858. Full Text
Lee, C-T, McClernon, FJ, Kollins, SH, and Fuemmeler, BF. "Childhood ADHD Symptoms and Future Illicit Drug Use: The Role of Adolescent Cigarette Use." Journal of pediatric psychology 43.2 (March 2018): 162-171. Full Text
Davis, NO, Bower, J, and Kollins, SH. "Proof-of-concept study of an at-home, engaging, digital intervention for pediatric ADHD." PloS one 13.1 (January 11, 2018): e0189749-. Full Text
Schechter, JC, Fuemmeler, BF, Hoyo, C, Murphy, SK, Zhang, JJ, and Kollins, SH. "Impact of Smoking Ban on Passive Smoke Exposure in Pregnant Non-Smokers in the Southeastern United States." International journal of environmental research and public health 15.1 (January 6, 2018). Full Text
Mitchell, JT, McIntyre, EM, English, JS, Dennis, MF, Beckham, JC, and Kollins, SH. "A Pilot Trial of Mindfulness Meditation Training for ADHD in Adulthood: Impact on Core Symptoms, Executive Functioning, and Emotion Dysregulation." Journal of attention disorders 21.13 (November 2017): 1105-1120. Full Text
McCullough, LE, Miller, EE, Calderwood, LE, Shivappa, N, Steck, SE, Forman, MR, A Mendez, M, Maguire, R, Fuemmeler, BF, Kollins, SH, D Bilbo, S, Huang, Z, Murtha, AP, Murphy, SK, Hébert, JR, and Hoyo, C. "Maternal inflammatory diet and adverse pregnancy outcomes: Circulating cytokines and genomic imprinting as potential regulators?." Epigenetics 12.8 (August 2017): 688-697. Full Text
Mitchell, JT, Weisner, TS, Jensen, PS, Murray, DW, Molina, BSG, Arnold, EL, Hechtman, L, Swanson, JM, Hinshaw, SP, Victor, EC, Kollins, SH, Wells, KC, Belendiuk, KA, Blonde, A, Nguyen, C, Ambriz, L, and Nguyen, JL. "How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning." Journal of attention disorders (February 2017): 1087054716685842-. Full Text
Childress, AC, Kollins, SH, Cutler, AJ, Marraffino, A, and Sikes, CR. "Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting." Journal of child and adolescent psychopharmacology 27.1 (February 2017): 66-74. Full Text
Schechter, JC, and Kollins, SH. "Prenatal Smoke Exposure and ADHD: Advancing the Field." Pediatrics 139.2 (February 2017). Full Text
Mitchell, JT, and Kollins, SH. "ADHD in adolescence." Adolescent health psychology. Ed. W O'Donohue, L Benuto, and L Tolle. Springer, 2013. 423-445. (Chapter)
Mitchell, JT, and Kollins, SH. "Attention-deficit/hyperactivity disorder in adolescence." Handbook of Adolescent Health Psychology. January 1, 2013. 423-445. Full Text
Kollins, SH. "Abuse potential of stimulant drugs used to treat ADHD." ADHD in Adults: Characterization, Diagnosis, and Treatment. January 1, 2011. 230-239. Full Text
Murphy, SK, Schrott, R, Visco, Z, Huang, Z, Grenier, C, Mitchell, J, Schechter, J, Lucas, J, Levin, ED, Price, T, and Kollins, SH. "Environment and Gametic Epigenetic Reprogramming." September 2017.
McClernon, FJ, Mitchell, JT, Schick, RS, Bayham, RL, Dennis, ME, Kollins, SH, and Beckham, JC. "COMBINED EMA AND GPS FOR ASSESSING THE SPATIAL DISTRIBUTION OF SMOKING BEHAVIOR: A PROOF OF CONCEPT STUDY." March 2013.
Bidwell, LC, Garrett, ME, McClernon, FJ, Fuemmeler, BF, Williams, RB, Ashley-Koch, AE, and Kollins, SH. "Genotype and ADHD symptoms interact to predict adolescents' early smoking experiences in an epidemiological sample." November 2011.
Witt, KL, Shelby, MD, Itchon-Ramos, N, Faircloth, M, Kissling, GE, Chrisman, AK, Ravi, H, Murli, H, Mattison, DR, and Kollins, SH. "Chromosomal aberrations, sister chromatid exchanges, and micronuclei in lymphocytes of pediatric ADHD patients treated with stimulant drugs." August 2008.
Goodman, D, Adler, L, Kollins, SH, Weisler, R, Krishnan, S, Zhang, Y, and Biederman, J. "Efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder." July 2008.
Kollins, SH, Wigal, T, Vince, B, Lyne, A, and Farrand, K. "Cognitive and sedative effects of guanfacine extended release in children and adolescents aged 6 to 17 years with attention-deficit/hyperactivity disorder: Safety and sleep effects." April 1, 2008.
Co-occurring ADHD in young children with ASD: Precursors, detection, neural signatures, and early treatment awarded by National Institutes of Health (Co-Principal Investigator). 2017 to 2022
Mobile health interventions for varenicline adherence among HIV-positive smokers awarded by National Institutes of Health (Co-Mentor). 2017 to 2022
Sleep Dysfunction and Neurocognitive Outcomes in Adolescent ADHD awarded by National Institutes of Health (Mentor). 2016 to 2021
Targeting reward dysfunction as a mechanism to improve smoking cessation awarded by National Institutes of Health (Co-Mentor). 2016 to 2021
Modeling the Neurobehavioral Basis of Extrinsic and Volitional Motivation in ADHD awarded by National Institutes of Health (Co-Sponsor). 2017 to 2020
Paternal Transgenerational Epigenetic Legacy from Use of Cannabis awarded by John Templeton Foundation (Co-Project Leader). 2017 to 2020
Effects of Nicotine Reduction on Smoking Behavior in ADHD Smokers awarded by National Institutes of Health (Principal Investigator). 2015 to 2020
Maternal obesity, child executive functions and child weight gain awarded by National Institutes of Health (Principal Investigator). 2015 to 2020
Smoking/Nicotine Dependence in Attention Deficit Hyperactivity Disorder (ADHD) awarded by National Institutes of Health (Principal Investigator). 2014 to 2019
A randomized, sham-controlled, crossover study to evaluate the effects of noise cancelling headphones on neurocognitive and academic outcomes in children and adolescents diagnosed with ADHD awarded by Bose Corporation (Principal Investigator). 2017 to 2019